e-learning
resources
London 2016
Wednesday, 07.09.2016
Cystic fibrosis: inflammation, microbiology, management and monitoring
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus
Ema Kavaliunaite (London, United Kingdom), Ema Kavaliunaite, Kathryn A. Harris, Paul Aurora, Garth Dixon, Delane Shingadia, Nagarajan Muthialu, Helen Spencer
Source:
International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Session:
Cystic fibrosis: inflammation, microbiology, management and monitoring
Session type:
Poster Discussion
Number:
4872
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ema Kavaliunaite (London, United Kingdom), Ema Kavaliunaite, Kathryn A. Harris, Paul Aurora, Garth Dixon, Delane Shingadia, Nagarajan Muthialu, Helen Spencer. LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus. Eur Respir J 2016; 48: Suppl. 60, 4872
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Cystic fibrosis and intestinal organoids
Asbestosis
Related content which might interest you:
Impact of isolation of
mycobacterium abscessus
on lung transplantation in CF patients
Source: Eur Respir J 2001; 18: Suppl. 33, 126s
Year: 2001
A patient with cystic fibrosis and Mycobacterium abscessus infection
Source: International Congress 2018 – CC1 Lung transplantation
Year: 2018
Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species
Source: Eur Respir J 2013; 41: 1230-1232
Year: 2013
Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
Source: Eur Respir J 2013; 41: 1101-1106
Year: 2013
Long-term survival of patients with
mycobacterium avium- intracellulare
complex pulmonary disease (MAC-PD)
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Isolation of
M. abscessus
from patients with
M. avium
complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Lung function evolution in patients with microbiological isolation of Mycobacterium abscessus
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Mycobacterium abscessus
respiratory infection: importance in immunosuppressed patients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008
Mycobacterium abscessus
infection in lung transplant patients: review of our series
Source: Annual Congress 2007 - Complications and success in lung transplantation
Year: 2007
Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis
Source: Eur Respir J 2015; 46: 707-716
Year: 2015
Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Pulmonary diseases caused by non-tuberculous mycobacteria
Source: Eur Respir Mon 2012; 58: 25-37
Year: 2012
Lung transplantation: Mycobacterium abscessus as a cause of graft dysfunction
Source: ISSN=ISSN 1810-6838, ISBN=, page=291
Year: 2007
Immune defects in patients with pulmonary
Mycobacterium abscessus
disease without cystic fibrosis
Source: ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020
Year: 2020
Mycobacterium abscessus
in patients with cystic fibrosis: low impact of inter-human transmission in Italy
Source: Eur Respir J, 50 (1) 1602525; 10.1183/13993003.02525-2016
Year: 2017
M
ycobacterium abscessus
pulmonary disease: individual patient data meta-analysis
Source: Eur Respir J, 54 (1) 1801991; 10.1183/13993003.01991-2018
Year: 2019
Do CT findings of Mycobacterium abscessus infection in patients with Cystic Fibrosis predict outcome?
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019
Survival of Mycobacterium abscessus isolated from people with cystic fibrosis in artificially generated aerosols
Source: Eur Respir J 2016; 48: 1789-1791
Year: 2016
Management of
Mycobacterium avium
complex and
Mycobacterium abscessus
pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022
Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection
Source: Eur Respir J 2015; 46: 1823-1826
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept